ClinicalTrials.gg
Drug

PEGPH20 clinical trials

Also written PEGPH20 and pegvorhyaluronidase alfa.

studies test it
16
open now
0
in phase 3
0
first study started
2009

How each study uses PEGPH20 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Pegylated Recombinant Human Hyaluronidase
3
PEGylated recombinant human hyaluronidase PH20
2

Development codes

PEGPH20
16

Other names

pegvorhyaluronidase alfa
2

Studies by the year they started

16 studies that test it; most in 2015 (3)

Studies that test PEGPH20, by start year
YearStudies
20091
20101
20111
20131
20142
20153
20161
20172
20192
20202

By phase

A phase 1/2 study counts in both.

Phase 1
8
Phase 2
9
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 8

Halozyme Therapeutics (7) · Memorial Sloan Kettering Cancer Center (2) · Hoffmann-La Roche (1) · SWOG Cancer Research Network (1) · Gulam Manji (1) · Andrew Ko (1) · Pancreatic Cancer Research Team (1) · M.D. Anderson Cancer Center (1)

Often tested with

Tested in the same studies.

Albumin-Bound Paclitaxel (1) · Paclitaxel (1) · Gemcitabine (1) · Cobimetinib (1) · Motixafortide (1) · Selicrelumab (1) · Bevacizumab (1) · Simlukafusp alfa (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test PEGPH20.

Studies

Open first, then newest update. How each study uses PEGPH20 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 16